CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Dupilumab Achieves Record $11.9 Billion in Global Sales Amidst Continued Growth

EarningsDupilumabPositive
AI Analysis

Summary

Dupilumab achieved record global sales of $11.9 billion, demonstrating continued commercial growth for the immunology asset.

Financial Highlights

Revenue

$11.9 billion

Importance:5/10
Sentiment:
0.80
salescommercialblockbusterrevenue
Related Companies

Read the original article

Published by yahoo_finance on July 3, 2026 8:40 AM

Read Original